Manufacturer record
Protech Telelinks: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
8 batches manufactured by Protech Telelinks (Himachal Pradesh) were declared Not of Standard Quality between February 2024 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: OP302501A, Neomycin Sulphate, Beclomethasone Dipropionate, Clotrimazole & Lignocaine Hydrochloride Ear Drops (exp Jun 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Schedule V of Drugs and Cosmetics Rules with respect to Assay of Neomycin Sulphate. Listed in the September 2026 alert.
Records by type
8 records linked to Protech Telelinks in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Neomycin Sulphate, Beclomethasone Dipropionate, Clotrimazole & Lignocaine Hydrochloride Ear Drops | Batch OP302501AMfg Jul 2025 · Exp Jun 2027 | The sample does not conform to claim as per Schedule V of Drugs and Cosmetics Rules with respect to Assay of Neomycin Sulphate, Beclomethasone Dipropionate and ClotrimazoleAssay | CDL, KolkataCDSCO lab | Sep 2026 |
| Amoxycillin & Potassium Clavulanate Injection IP 1200 mg | Batch D0092509AMfg Feb 2025 · Exp Jan 2027 | The sample does not conform to IP with respect to the Assay of Clavulanic Acid.Assay | CDL, KolkataCDSCO lab | Sep 2026 |
| Labetalol Injection IP | Batch L0422420FMfg Dec 2024 · Exp Nov 2026 | pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab | Oct 2025 |
| Iron Sucrose Injection USP (Irolink Injection), | Batch L0372321CMfg Oct 2023 · Exp Sep 2025 | SterilitySterility | State Lab KarnatakaState lab | Jun 2025 |
| Aciclovir Intravenous Infusion IP 250 mg (Acyclotech Injection) | Batch D0072406BMfg Jun 2024 · Exp May 2026 | Assay of AciclovirAssay | RDTL ChandigarhCDSCO lab | Oct 2024 |
| Heparin Sodium Injection IP 5000 IU / 5ml (Hepathin 5000 Injection 5 ml / vial) | Batch L1192317GMfg Aug 2023 · Exp Jul 2025 | Description & Particulate matterDescription | CDL KolkataCDSCO lab | Sep 2024 |
| Heparin Sodium Injection IP 5000 IU / 5ml (Hepathin 5000 Injection 5 ml / vial) | Batch L1192317CMfg Aug 2023 · Exp Jul 2025 | Description, Particulate matter and Assay of Heparin (Anti- factor IIa activity)Assay | CDL KolkataCDSCO lab | Sep 2024 |
| Propofol Injection IP 500 mg/50 ml (Hyprovan 500 Injection) | Batch L3352301AMfg Jun 2023 · Exp May 2025 | Assay of PropofolAssay | CDL KolkataCDSCO lab | Feb 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.